A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
New findings suggest that narrow-spectrum UV light could dramatically reduce surgical infections – which remain a serious and stubborn problem, killing up to 8,200 patients a year in the U.S. – without damaging human tissue
The new Irving Radiation Oncology Center, a 12,500-square-foot facility, provides leading-edge precision radiation therapies and the most advanced diagnostic imaging for children and adults with cancer.
Celiac disease patients with ongoing intestine damage have a greater than 2-fold increased risk of lymphoma compared with those whose intestines healed.